Symposium: Rare Diseases in Neurology
The event focuses on recent advances in rare neurological and neurodevelopmental disorders across the lifespan. Topics include the transition of neurodevelopmental disorders from childhood to adulthood, new perspectives on autoimmune encephalitis, and challenges in rare childhood neurological disorders from clinical care to cellular research models. Emerging therapies such as N-Acetyl-L-Leucine and Fampridine for rare neurological diseases are discussed, alongside new insights into the expanding spectrum of rare dystonic syndromes and future precision medicine approaches.
Coordination: PD T. Brémovà-Ertl, Prof. U. Fischer
Program
Rare Neurological Diseases as an Evolving Hot Topic in Neurology
|
14.00 |
Welcome and Brief Introduction |
|
|
Moderation: Tatiana Brémovà-Ertl, Jan Bernhard Hofmann |
||
|
14.00–14.45 |
Keynote Lecture 1 |
|
|
Neurodevelopmental Disorders: From Childhood to Adulthood |
||
|
14.45–15.15 |
Autoimmune Encephalitis: More than a Rare Neurological Disease |
|
|
15.15–15.35 |
Coffee break |
|
|
Moderation: Smaila Mulic-Al Bunni, Chiara Brechbühl |
||
|
15.35–16.05 |
Challenges in Rare Childhood Neurological Disorders: From Bedside to Cellular Models |
|
|
16.05–16.35 |
N-Acetyl-L-Leucine and Fampridine for RNDs: An Overview and Outlook |
|
|
Keynote Lecture 2 |
||
|
16.35–17.05 |
Expanding Spectrum of Rare Dystonic Syndromes |
|
|
17.05–17.30 |
Discussion; Swiss Network for Rare Neurological Disorders of the CNS and its subnetworks |
Tatiana Brémovà-Ertl, Georg Kägi, Alexander Tarnutzer, Georgia Ramantani |
|
17.30 |
Closing Remarks and Aperitif |
Endorsement
